AstraZeneca (AZN)

• Market cap: $277B
• 1 day: -5.7%
• 5 days: -5.82%
• 1 month: -2.69%
• 3 months: -12.93%
• 6 months: -5.71%
• Year to date: -2.54%
• 1 year: 26.02%
• 5 years: 49.66%
• 10 years: 197.78%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Employees: 96,100